ArticleOncoimmunology2019

Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg

Lijie Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.